Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has shared an update.
Charmacy Pharmaceutical Co., Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for May 22, 2025, in Guangzhou City, China. The meeting will address several key resolutions, including the approval of the 2024 financial reports, amendments to meeting procedures, profit distribution plans, director remuneration, and the re-appointment of auditors. Additionally, the company plans to apply for a comprehensive revolving credit line of up to RMB 2.8 billion, which could significantly impact its financial flexibility and operational strategy.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in China, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products, focusing on the Chinese market.
YTD Price Performance: -20.92%
Average Trading Volume: 2,000
Technical Sentiment Signal: Buy
Current Market Cap: HK$837M
For an in-depth examination of 2289 stock, go to TipRanks’ Stock Analysis page.